In recent years, the discovery of new autoantigens and the use of sensitive assays have expanded the clinical spectrum of myasthenia gravis (MG). In particular, antibodies binding to clustered acetylcholine receptors and to the low-density lipoprotein receptor-related protein 4 have not only bridged a significant gap in diagnosis but also have relevant clinical implications. MG management includes different therapeutic options, from symptomatic agents as the only therapy in mildly affected cases to combined long-term immunosuppression and thymectomy in patients with severe disabling disease. MG biological diversity can influence the response to therapies and should be taken into account when planning treatment. Biologic agents are promising, though their use is currently limited to patients with refractory disease.

Evoli, A., Iorio, R., Bartoccioni, E., Overcoming challenges in the diagnosis and treatment of myasthenia gravis, <<EXPERT REVIEW OF CLINICAL IMMUNOLOGY>>, 2015; 2015 (N/A): 1-12. [doi:10.1586/1744666X.2016.1110487] [http://hdl.handle.net/10807/70201]

Overcoming challenges in the diagnosis and treatment of myasthenia gravis

Evoli;Amelia; Iorio;Raffaele; Bartoccioni
2015

Abstract

In recent years, the discovery of new autoantigens and the use of sensitive assays have expanded the clinical spectrum of myasthenia gravis (MG). In particular, antibodies binding to clustered acetylcholine receptors and to the low-density lipoprotein receptor-related protein 4 have not only bridged a significant gap in diagnosis but also have relevant clinical implications. MG management includes different therapeutic options, from symptomatic agents as the only therapy in mildly affected cases to combined long-term immunosuppression and thymectomy in patients with severe disabling disease. MG biological diversity can influence the response to therapies and should be taken into account when planning treatment. Biologic agents are promising, though their use is currently limited to patients with refractory disease.
Inglese
Evoli, A., Iorio, R., Bartoccioni, E., Overcoming challenges in the diagnosis and treatment of myasthenia gravis, <<EXPERT REVIEW OF CLINICAL IMMUNOLOGY>>, 2015; 2015 (N/A): 1-12. [doi:10.1586/1744666X.2016.1110487] [http://hdl.handle.net/10807/70201]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/70201
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 6
social impact